PTPRC and leukemia: To efficiently compare the binding sites for wild-type KMT2A and fusion proteins, we applied AutoCUT&RUN22 across a panel of four KMT2Ar leukemia cell lines and eight primary KMT2Ar patient samples sorted for CD45+ blasts.